首页> 外文OA文献 >Evaluation of the Anxiolytic Activity of NR-ANX-C (a Polyherbal Formulation) in Ethanol Withdrawal-Induced Anxiety Behavior in Rats
【2h】

Evaluation of the Anxiolytic Activity of NR-ANX-C (a Polyherbal Formulation) in Ethanol Withdrawal-Induced Anxiety Behavior in Rats

机译:NR-ANX-C(一种多草药配方)在乙醇戒断所致大鼠焦虑行为中的抗焦虑活性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study investigates the anxiolytic activity of NR-ANX-C, a standardized polyherbal formulation containing the extracts of Withania somnifera, Ocimum sanctum, Camellia sinensis, Triphala, and Shilajit in ethanol withdrawal- (EW-) induced anxiety behavior in rats. Ethanol dependence in rats was produced by substitution of drinking water with 7.5% v/v alcohol for 10 days. Then, ethanol withdrawal was induced by replacing alcohol with drinking water, 12 hours prior to experimentation. After confirming induction of withdrawal symptoms in the alcohol deprived animals, the anxiolytic activity of the test compound in graded doses (10, 20, and 40 mg/kg) was compared to the standard drug alprazolam (0.08 mg/kg) in the elevated plus maze and bright and dark arena paradigms. In our study, single and repeated dose administration of NR-ANX-C reduced EW-induced anxiety in a dose-dependent manner. Even though the anxiolytic activity was not significant at lower doses, NR-ANX-C at the highest dose tested (40 mg/kg) produced significant anxiolytic activity that was comparable to the standard drug alprazolam. Based on our findings we believe that NR-ANX-C has the potential to be used as an alternative to benzodiazepines in the treatment of EW-induced anxiety.
机译:本研究调查了NR-ANX-C(一种标准化的多草药制剂)的抗焦虑活性,该制剂包含Withania睡茄,Ocimum Sanctum,Camellia sinensis,Triphala和Shilajit的提取物在大鼠乙醇戒断(EW-)中引起的焦虑行为。通过用7.5%的v / v酒精代替饮用水10天来产生大鼠对乙醇的依赖性。然后,在实验前12小时,用饮用水代替酒精以诱导乙醇排出。在确认了酒精缺乏动物的戒断症状的诱发后,将分级剂量(10、20和40μmg/ kg)的受试化合物的抗焦虑活性与标准药物阿普唑仑(0.08μmg/ kg)进行比较。迷宫和黑暗与黑暗的竞技场范例。在我们的研究中,NR-ANX-C的单次和重复给药以剂量依赖性方式减少了EW引起的焦虑。即使在较低剂量下抗焦虑活性不明显,但在最高测试剂量(40μmg/ kg)下,NR-ANX-C仍产生了与标准药物阿普唑仑相当的显着抗焦虑活性。根据我们的发现,我们相信NR-ANX-C在治疗EW引起的焦虑症方面有潜力替代苯二氮卓类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号